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the surface. The planned and the histological ablation zones 
were compared, analysed per individual patient and per 
protocol (focal vs. extended).
Results All cells within the electrode configuration were 
completely ablated and consisted only of necrotic and 
fibrotic tissue without leaving any viable cells. The histo-
logical ablation zone was always larger than the electrodes 
configuration (2.9 times larger for the 3 electrodes configu-
ration and 2.5 times larger for the ≥4 electrode configura-
tion). These ablation effects extended beyond the prostatic 
capsule in the neurovascular bundle in 13 out of 15 cases.
Conclusions IRE in prostate cancer results in completely 
ablated, sharply demarcated lesions with a histological 
ablation zone beyond the electrode configuration. No skip 
lesions were observed within the electrode configuration.
Clinical trials ClinicalTrials.gov Identifier: NCT01790451 
https://clinicaltrials.gov/ct2/show/NCT01790451
Keywords Irreversible electroporation · IRE · Prostate 
cancer · Planning · IRE · Focal therapy
Introduction
Prostate cancer has become the most prevalent cancer in 
men and forms a significant health risk in the Western world 
[1]. PSA tests are currently performed regularly and imag-
ing techniques have improved, leading to a considerably 
increased detection of localized prostate cancer [1]. The 
current treatment options for localized prostate cancer are 
active surveillance and therapy with curative intent (sur-
gery or radiotherapy), depending on the stage of the tumour 
and patients’ consideration. A variety of ablative therapies 
has been introduced for treatment of localized prostate can-
cer. It functions as middle ground between the traditional 
Abstract 
Purpose Irreversible electroporation (IRE) is a novel 
minimally invasive therapy for prostate cancer using short 
electric pulses to ablate prostate tissue. The purpose of 
this study is to determine the IRE effects in prostate tissue 
and correlate electrode configuration with the histology of 
radical prostatectomy (RP) specimens. We hypothesize that 
the area within the electrode configuration is completely 
ablated and that the area within the electrode configuration 
is predictive for the ablated area after treatment.
Methods A prospective phase I/II study was conducted in 
16 consecutive patients with histopathologically confirmed 
prostate cancer scheduled for RP. Focal or extended IRE 
treatment of the prostate was performed 4 weeks prior to 
RP. The locations of the electrodes were used to calculate 
the planned ablation zone. Following RP, the specimens 
were processed into whole-mount sections, histopathology 
(PA) was assessed and ablation zones were delineated. The 
area of the tissue alteration was determined by measuring 
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options. The rationale behind these so-called focal thera-
pies is to target only the tumourous areas and leave healthy 
tissue and adjacent structures intact. Most used ablative 
technologies are cryotherapy, high-intensity focused ultra-
sound (HIFU) and radiotherapy [2]. A novel technique in 
the armamentarium is irreversible electroporation (IRE). It 
uses pulsed high-voltage low-energy direct electric current 
for ablation. The electric energy is delivered through nee-
dle-electrodes, placed circumferential around the tumour 
zone. Cell-membrane potentials are disturbed by the con-
secutive high-voltage (usually around 1500 V/cm) electric 
pulse trains between at least two spatially separated elec-
trodes, which leads to irreversible permeability of cell mem-
branes and results in apoptotic cell death [3]. Literature on 
IRE reports advantages as sparing surrounding vital struc-
tures including blood vessels and connective tissue [4]. By 
sparing these structures unharmed, patients might maintain 
their potency and continence. Successfully treating prostate 
cancer requires an accurate prediction of the treatment zone 
through treatment planning. Planning of IRE is currently 
based on mathematical and numerical models in multicel-
lular tissue models and animals studies [5–7]. The aim of 
this study was to assess the IRE ablation zone in specimens 
from radical prostatectomies by using different ablation pro-
tocols and to correlate the cross-sectional ablation zone on 
histopathology with the electrode configuration. We hypoth-
esize that (1) the area within the electrode configuration is 
completely ablated; (2) the area within the electrode config-
uration is predictive for the cross-sectional ablated area after 
treatment, irrespective to the used ablation protocol.
Methods
Setting
Sixteen patients with confirmed localized prostate can-
cer, scheduled for a radical prostatectomy, were enrolled 
between August 2013 and April 2014 to undergo an IRE 
treatment approximately 4 weeks prior to RP. The patients’ 
mean age was 60 years (range 44–75) and had an aver-
age serum prostate specific antigen (PSA) concentration 
of 9.5 µg/L (range 4.4–22.5). Patient’s characteristics are 
shown in Table 1. Twelve patients were treated at the uni-
versity hospital in Amsterdam and four patients in the uni-
versity hospital in Athens. The institutional review boards 
of both hospitals approved the study. Written informed con-
sent was obtained from every patient.
IRE procedure
The IRE procedure was performed using transperineally 
inserted electrodes through a brachytherapy grid under 
continuous ultrasound guidance. The location of each elec-
trode and the distances between the electrode pairs were 
assessed on ultrasound and used as prediction of the abla-
tion zone.
The IRE treatment was performed using the Nanoknife® 
(AngioDynamics Inc., Queensbury, NY) (Fig. 1). A low-
energy direct current generator delivering high-voltage 
pulses by 19-gauge monopolar electrode needles. The 
procedures are performed under general anaesthesia. An 
electrocardiogram (ECG)-gating device (Accusync, Mil-
ford, Connecticut) was used to synchronize pulse delivery 
within the refractory period of the heart to prevent cardiac 
arrhythmias. Rocuronium was intravenously administered 
to achieve adequate muscle relaxation and was confirmed 
by twitch absence using a peripheral nerve stimulation test.
The IRE treatment was performed following a focal or 
extended ablation protocol. To achieve focal prostate abla-
tion, one 2- and five 3-electrode configurations were per-
formed. Ten extended ablations were performed using 
four or more electrodes. The active exposure length of the 
electrodes was set on 15 mm. The electrodes delivered 90 
pulses of 90 μs duration each between every pair, with a 
Table 1  Patient characteristics
Patients (N = 16)
Age (years) 60 (range 44–75)
Serum PSA (µg/L) 9 (range 3.6–25)
Prostate volume (mL) 39 (range 19–60)
Gleason score (TRUS-guided biopsy)
 3 + 3 8
 3 + 4 3
 4 + 3 3
 4 + 4 2
Disease distribution (TRUS-guided biopsy)
 Unilateral 11
 Bilateral 5
Gleason score (RP specimen)
 No tumour present 1
 3 + 3 7
 3 + 4 6
 4 + 3 1
 3 + 5 1
 4 + 4 0
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pulse intensity set at 1500 V/cm (voltage-to-distance ratio). 
A current of 20–40 A runs during the pulse. The standard 
setting of 1500 V per cm distance between the needles was 
adapted when the current showed low amperage or high 
amperage, with a maximum of 3000 V. All electrodes were 
inserted at a distance of at least 5 mm from the rectal wall. 
In one patient, a pullback of 15 mm of all four electrodes 
was performed after the first ablation to increase the length 
of the ablation zone. During another procedure of a four-
electrode configuration, the two lateral electrodes were 
repositioned after one ablation cycle to the other lobe, (cov-
ering the urethra) in order to perform a bilateral ablation. 
At this phase of research, the IRE treatment was not per-
formed with curative intent. The electrodes were inserted 
in a lobe found positive by biopsy, however, exact targeting 
of the tumour was not pursued. The procedures and IRE 
device are described in detail in van den Bos et al. [8].
Treatment prediction
The area within the electrode configuration was determined 
by the locations of the inserted electrodes as measured on 
the ultrasound images as indicated in Fig. 2a (focal abla-
tion protocol) and in Fig. 3a (extended ablation protocol). 
The area within the configuration was delineated (Figs. 2b, 
3b). Ultrasound imaging was scaled using the grid on the 
images, and the areas within the electrodes were deter-
mined using image analysis software ImageJ/FIJI. These 
areas were used as prediction of the ablation zone.
Histology assessment
Macroscopic assessment and processing included measure-
ment of size and weight, and orientation was achieved by 
using multiple colours for different planes. After formalin 
fixation the prostate was cut into serial sections of 3–5 mm 
thickness, perpendicularly to the urethra. The tissue was 
embedded in paraffin after which 4-µm-thick sections were 
cut and examined with an H&E stain. The characteristics 
of both the ablation zone (PA) and non-ablated zone were 
determined by light microscopy. The tissue is considered 
affected by IRE if the cells showed necrosis and/or denuda-
tion in case of epithelial tissue and necrosis and denuda-
tion are easily seen on an H&E slide. The margins of the 
Fig. 1  Patient in lithotomy 
position with three transperine-
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a b
c d
Fig. 2  a Ultrasound image showing the three inserted electrodes. b 
The area within the electrode configuration is delineated. c H&E slide 
with the outlined ablation zone. d The ablation zone is delineated
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ablation zone and tumour zones were delineated on the 
slides (Figs. 2c, d, 3c, d ). Furthermore, any affected essen-
tial structure (urethra, capsule, neurovascular bundle) was 
determined per patient and scored by the uropathologists. 
The correlation of the distance between electrodes and 
essential structures was measured in mm using ultrasound 
images. Because of non-normal distributed, non-paired 
data, statistical analysis was performed using a two-tailed 
Mann–Whitney test.
Histology ablation areas
The edited slides were scanned 40X with the IntelliSite 
Ultra-Fast Scanner (Philips, Best, The Netherlands), and 
the areas of tissue alterations were determined by segmen-
tation as designated by the pathologists. Subsequently, the 
slide representing the centre of the ablation zone, contain-
ing the most expanded ablation, was determined. The pre-
cisely outlined areas were scaled using the dimensions of 
the microscope slide. The ablation areas were calculated 
with the use of ImageJ/Fiji. The extracted cross-sectional 
ablation zones were adjusted for shrinkage during fixation 
using the pre-fixation prostate dimension divided by the 
post-fixation dimension.
Electrode configuration and histology correlation
To assess whether the electrode configuration correlates 
to PA, all the areas within the inserted electrodes (in cm2) 
were directly compared and matched with the cross-sec-
tional histology areas.
Analysis of focal versus extended ablation zones
It was hypothesized that no difference would be assessed 
between the two ablation protocols in the comparison of 
the predicted and histological determined ablation areas. To 
test validity, the factorial difference between the predicted 
and histology area in cm2 is plotted for the two protocols by 
dividing histology analysis by the electrode configuration.
Results
IRE procedure
Six patients were treated using the focal ablation protocol. 
The extended protocol was performed in the remaining ten 
patients. All the procedures went uneventful, and no seri-
ous adverse events were observed during the procedure or 
hospital stay. None of the patients have been withdrawn 
because of adverse events. The voltage-to-distance ratios 
ranged from 1200 to 2100 V/cm with currents between 
15 and 45 A. The procedure specifications per patient are 
shown in Table 2.
Histology assessment
Gross examination showed sharply demarcated haemor-
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Fig. 3  a Ultrasound image showing the four inserted electrodes. b 
The area within the electrode configuration is delineated. c H&E slide 
with the outlined ablation zone. d The ablation zone is delineated
Table 2  Procedure specifications






1 2 1500 15–18
2 3 1500–1700 22–28
3 4 1500 21–42
4 4 1200–1500 22–45
5 3 1500–1800 26–35
6 4 + pullback 1350–1500 25–45
7 3 1500–1650 22–28
8 6 1350–1500 25–40
9 4 1500–1800 25–38
10 4 1500 23–35
11 3 1500–1800 21–31
12 4 1500–1650 32–42
13 4 1500–1800 20–40
14 4 1500–1950 21–30
15 3 1500–2100 18–25
16 3 1500 22–32
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the specimen of patient one where only two electrodes 
were used. Microscopic assessment showed haemorrhagic, 
necrotic and fibrotic areas in all cases, again except for 
patient one. In the first patient the specimen contained only 
fibrotic tissue with a bilateral extension, without any rela-
tion to the unilaterally inserted electrodes. This patient was 
the only one treated with two electrodes with a low cur-
rent output (15–18 A), what is considered as insufficient by 
the manufacturer. Therefore, the case was excluded from 
further histological analysis. All other prostate specimens 
showed sharply delineated ablation zones with completely 
non-viable tissue consisting of necrotic and fibrotic tissue 
within the electrode configuration. The IRE effects com-
prised areas ranged from 5 to 40 % of the total prostate 
tissue.
Electrode configuration–histology association
The areas traced within the electrode configuration (in 
mm2) were compared with the area on the H&E PA image 
and are displayed per patient in Fig. 4 for the focal ablation 
protocol and in Fig. 5 for the extended ablation protocol. 
The results, grouped per protocol, are shown in Figs. 6 and 
7, respectively. None of the patients had skip lesions within 
the configuration of the electrodes. When using the focal 
ablation protocol, the histological analysis showed ablation 
zones of 2.9 times (range 1.3–4.0) greater than the area of 
the electrode configuration. Using the extended ablation 
protocol, the histological analysis showed ablation zones of 
2.5 times (range 1.1–4.3) greater than the electrode config-
uration. Patient 4 in the focal protocol and patient 4 and 6 in 
the extended protocol appeared as outliers, with a relatively 
small ablation area. These variant outcomes could not be 
explained by the prostate tissue composition including the 
presence of glandular hyperplasia, inflammation, atrophy, 
Gleason score or prostate size. The factorial outcomes were 
presented per ablation protocol in Fig. 8. No significant dif-
ference was found between these outcomes.
IRE effects were observed extending beyond the pro-
static capsule in twelve cases and in the neurovascular 
bundle in thirteen of the fifteen prostates. The urethra was 
affected due to IRE treatment in nine prostates. Chronic 
inflammation varied from mild to moderate with only one 
cases showing focal severe inflammation. Statistical analy-
sis of affected versus unaffected tissue structures revealed 
Fig. 4  The areas within the electrode configuration and the cross-
sectional areas of the histology analysis of the focal ablation protocol, 
presented per patient. The results outlined in green are from the same 
patient as displayed in green are from the same patient as displayed 
in Fig. 2
Fig. 5  The areas within the electrode configuration and the cross-
sectional areas of the histology analysis of the extended ablation pro-
tocol, presented per patient. The results outlined in green are from the 
same patient as displayed in Fig. 3
Fig. 6  Boxplots showing the average results of the areas electrode 
configuration of the focal ablation protocol and the outcomes of the 
histology analysis
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no difference between structures close to or at distance to 
the inserted electrodes (urethra P value 0.47, IQR = 5.8–
9.6, prostatic capsule P value 1.0 IQR = 5.0–6.4), neuro-
vascular bundle P value = 0.38, IQR 4.9–6.3) as shown in 
Fig. 9.
Discussion
The present study was designed to determine whether IRE 
was able to achieve complete cell death. It is crucial for 
ablative therapies to secure that the targeted zone is entirely 
ablated, without leaving any viable cells. In this study, the 
histology outcomes confirm that IRE effectively ablates all 
prostate tissue enclosed within the area of the inserted elec-
trodes. The first examined viable cells were localized at the 
borders of the ablation zone. All inserted electrodes were 
placed with at least 5 mm distance to the rectal wall. During 
follow-up, no clinically significant adverse events concern-
ing rectal wall damage occurred. The evaluation of the exact 
safe margin to be kept from the rectum was beyond the scope 
of this trial; however, in four instances a margin between 4.5 
and 6.0 mm was kept with no subsequent adverse events.
Similar studies performing ablative therapies followed 
by RP show various results. Pisters et al. [9] did not achieve 
complete tumour destruction with whole-gland cryotherapy 
in three of the seven patients. Grampsas et al. [10] reported 
the potential for salvage radical prostatectomy in biopsy-
proven recurrences of the 62 evaluated cases treated with 
complete cryoablation. Six of these patients underwent a 
salvage radical prostatectomy showing necrotic tissue in 
the area of probe-placement with a sharp border demar-
cating these regions from the adjacent viable oedematous 
connective tissue. The whole-mount sections of the prostate 
specimen revealed residual prostate cancer after supposed 
successful cryoablation. Two comparable studies were per-
formed to evaluate the histological impact and efficacy of 
transrectal HIFU. Beerlage et al. [11] showed incomplete 
necrosis at the dorsal side of the prostate in all treated 
patients. In two of the nine cases, this area contained vital 
tumour tissue. Madersbacher et al. [12] achieved a success-
ful ablation in three out of ten participating patients using 
HIFU. In the remaining seven patients, the tumour was 
partly targeted but persistent tumour tissue was found with 
histopathological examination. These studies showed that 
complete tissue destruction was not achieved in all partici-
pants. In contrast, our study using IRE ablation showed that 
within the targeted area all cells were destroyed. Several 
other papers, mostly based on canine studies, confirm our 
findings using the IRE technology [5], [12], [13]. However, 
the sizes of the ablation areas in histology are much larger 
than the configuration, with a factor of 2.7 on average. An 
explanation is that the ablation zone follows the electrical 
field (E-field) and this expands beyond the electrodes like 
described in the mathematical model of irreversible elec-
troporation by Edd and Davalos [5]. Also potential thermal 
properties accompanying the IRE effects like described by 
Wagstaff et al. [13] may enlarge the ablation area.
Limitations of our study include possible shrink-
age artefacts and the short term of follow-up of 4 weeks. 
During these 4 weeks following the IRE procedure, the 
inflammatory and fibrotic processes resulting in necrosis 
Fig. 7  Boxplots showing the average results of the areas electrode 
configuration of the extended ablation protocol and the outcomes of 
the histology analysis
Fig. 8  Boxplots showing the factorial outcomes between the areas of 
the electrode configuration and the histology analysis displayed per 
group. The red line represents the average of the factorial outcomes 
from the two ablation protocol
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causes deformation of the prostate gland. An additional 
limitation is the small sample size of sixteen patients. 
Therefore, the results may not be generalised to all pros-
tate cancer patients. A successive randomized clinical 
trial covering the next phase has already started under the 
umbrella of the Clinical Research Office of the Endouro-
logical Society (CROES) and aims to include 200 patients 
(NCT01835977). The study was also limited by the maxi-
mal follow-up of 4 weeks due to the need for RP in these 
patients. Although longer follow-up is desirable, postpon-
ing the scheduled RP was ethically no option. Actually, it 
is believed that the duration of the follow-up was sufficient 
since the histology showed necrotic and fibrotic elements 
implying the IRE effects were beyond the early effects of 
the treatment (inflammation) and before longer-term effects 
(fibrosis and repair). Interestingly, the first IRE treatment 
in our study was performed using a unilateral two-elec-
trode configuration. Histological analysis did not show 
any necrotic area but diffuse bilateral fibrosis throughout 
the prostate. The reported current ranged from 15 to 18 A. 
Dunki-Jacobs et al. [14] stated that the change in resistance 
and the slope of the resistance should be used to assess 
successful tumour ablation during IRE in pancreas. The 
small change in current with an increase of 3 A of case 1 
may imply an unsuccessful ablation. However, Neal et al. 
[15] performed 5 IRE treatments using two electrodes (1 
in canine prostate and 4 in human prostate) generating low 
currents and high currents and the specimens all showed 
an ablation zones with a necrotic focus. Proper evaluation 
of an electrode configuration requires multiple repetitions. 
Since there was only one case with a two-electrode config-
uration and low current, the cause of the unsuccessful abla-
tion remains unclear.
The findings of our study are important since it docu-
ments the targeted zone within the needles configuration 
where all cancer will be eradicated.
Conclusion
Although IRE in prostate cancer results in a completely 
ablated, sharply demarcated ablation areas without leaving 
any viable cell within the electrode configuration. The elec-
trode configuration using the focal ablation protocol and 
the extended ablation protocol, respectively, results in a 2.9 
and 2.5 times greater cross-sectional histological ablation 
zone.
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